Page 56 - Read Online

Neurol 2002;22:105-22. Karageorgiou KE, Dalakas MC, Tzioufas AG. Reactivity to AQP4
6. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, epitopes in relapsing-remitting multiple sclerosis. J Neuroimmunol
Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody 2013;260:117-20.
marker of neuromyelitis optica: distinction from multiple sclerosis. 29. Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K,
Lancet 2004;364:2106-12. Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H,
7. Devic E. Myelite subaigue compliquee de nevrite optique. Bull Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J,
Med (Paris) 1894;8:1033-4. Kristoferitsch W, Berger T, Reindl M. Complement activating
8. Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis
The clinical course of neuromyelitis optica (Devic’s syndrome). optica and related disorders. J Neuroinflammation 2011;8:184.
Neurology 1999;53:1107-14. 30. Iyer A, Elsone L, Appleton R, Jacob A. A review of the current
9. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, literature and a guide to the early diagnosis of autoimmune
Weinshenker BG. Revised diagnostic criteria for neuromyelitis disorders associated with neuromyelitis optica. Autoimmunity
optica. Neurology 2006;66:1485-9. 2014;47:154-61.
10. Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, 31. Wingerchuk DM, Weinshenker BG. The emerging relationship
Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, between neuromyelitis optica and systemic rheumatologic
Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL. Clinical autoimmune disease. Mult Scler 2012;18:5-10.
characteristics of African Americans vs Caucasian Americans with 32. Avidan N, Le Panse R, Berrih-Aknin S, Miller A. Genetic basis
multiple sclerosis. Neurology 2004;63:2039-45. of myasthenia gravis - a comprehensive review. J Autoimmun
11. Cabre P, Heinzlef O, Merle H, Buisson GG, Bera O, Bellance R, 2013;52:146-53.
Vernant JC, Smadja D. MS and neuromyelitis optica in 33. Schluep M, Willcox N, Vincent A, Dhoot GK, Newsom-Davis J.
Martinique (French West Indies). Neurology 2001;56:507-14. Acetylcholine receptors in human thymic myoid cells in situ: an
12. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol immunohistological study. Ann Neurol 1987;22:212-22.
2003;2:117-27. 34. Wekerle H, Ketelsen UP. Intrathymic pathogenesis and dual genetic
13. Das A, Puvanendran K. A retrospective review of patients with control of myasthenia gravis. Lancet 1977;1:678-80.
clinically definite multiple sclerosis. Ann Acad Med Singapore 35. Leite MI, Jones M, Ströbel P, Marx A, Gold R, Niks E, Verschuuren JJ,
1998;27:204-9. Berrih-Aknin S, Scaravilli F, Canelhas A, Morgan BP, Vincent A,
14. Gangopadhyay G, Das SK, Sarda P, Saha SP, Gangopadhyay PK, Willcox N. Myasthenia gravis thymus: complement vulnerability
Roy TN, Maity B. Clinical profile of multiple sclerosis in Bengal. of epithelial and myoid cells, complement attack on them, and
Neurol India 1999;47:18-21. correlations with autoantibody status. Am J Pathol 2007;171:893-905.
15. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, 36. Giraud M, Taubert R, Vandiedonck C, Ke X, Lévi-Strauss M,
de Almeida AM, Oliveira S, Basilio De Oliveira CA, Alvarenga H, Pagani F, Baralle FE, Eymard B, Tranchant C, Gajdos P, Vincent A,
Poser CM. Optic neuromyelitis syndrome in Brazilian patients. Willcox N, Beeson D, Kyewski B, Garchon HJ. An IRF8-binding
J Neurol Neurosurg Psychiatry 2002;73:429-35. promoter variant and AIRE control CHRNA1 promiscuous
16. Misu T, Fujihara K, Nakashima I, Miyazawa I, Okita N, Takase S, expression in thymus. Nature 2007;448:934-7.
Itoyama Y. Pure optic-spinal form of multiple sclerosis in Japan. 37. Zéphir H, Fajardy I, Outteryck O, Blanc F, Roger N, Fleury M,
Brain 2002;125:2460-8. Rudolf G, Marignier R, Vukusic S, Confavreux C, Vermersch P, de
17. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Seze J. Is neuromyelitis optica associated with human leukocyte
Is Devic’s neuromyelitis optica a separate disease? A comparative antigen? Mult Scler 2009;15:571-9.
study with multiple sclerosis. Mult Scler 2003;9:521-5. 38. Fukazawa T, Yamasaki K, Ito H, Kikuchi S, Minohara M, Horiuchi I,
18. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E, Tsukishima E, Sasaki H, Hamada T, Nishimura Y, Tashiro K, Kira J.
Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G; Italian Devic’s Both the HLA-CPB1 and -DRB1 alleles correlate with risk for
Study Group (IDESG). Clinical characteristics, course and prognosis multiple sclerosis in Japanese: clinical phenotypes and gender as
of relapsing Devic’s neuromyelitis optica. J Neurol 2004;251:47-52. important factors. Tissue Antigens 2000;55:199-205.
19. Davis R, Thiele E, Barnes P, Riviello JJ Jr. Neuromyelitis optica in 39. Isobe N, Matsushita T, Yamasaki R, Ramagopalan SV, Kawano Y,
childhood: case report with sequential MRI findings. J Child Neurol Nishimura Y, Ebers GC, Kira J. Influence of HLA-DRB1 alleles on
1996;11:164-7. the susceptibility and resistance to multiple sclerosis in Japanese
20. Filley CM, Sternberg PE, Norenberg MD. Neuromyelitis optica in patients with respect to anti-aquaporin 4 antibody status. Mult Scler
the elderly. Arch Neurol 1984;41:670-2. 2010;16:147-55.
21. Matiello M, Kim HJ, Kim W, Brum DG, Barreira AA, Kingsbury DJ, 40. Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K,
Plant GT, Adoni T, Weinshenker BG. Familial neuromyelitis optica. Sato S, Kawano Y, Kira J; South Japan Multiple Sclerosis Genetics
Neurology 2010;75:310-5. Consortium. Distinct genetic and infectious profiles in Japanese
22. Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y. Intractable neuromyelitis optica patients according to anti-aquaporin 4 antibody
hiccup and nausea with periaqueductal lesions in neuromyelitis status. J Neurol Neurosurg Psychiatry 2013;84:29-34.
optica. Neurology 2005;65:1479-82. 41. Wang H, Dai Y, Qiu W, Zhong X, Wu A, Wang Y, Lu Z, Bao J,
23. Poppe AY, Lapierre Y, Melançon D, Lowden D, Wardell L, Hu X. HLA-DPB1*0501 is associated with susceptibility to
Fullerton LM, Bar-Or A. Neuromyelitis optica with hypothalamic anti-aquaporin-4 antibodies positive neuromyelitis optica in
involvement. Mult Scler 2005;11:617-21. southern Han Chinese. J Neuroimmunol 2011;233:181-4.
24. Magaña SM, Matiello M, Pittock SJ, McKeon A, Lennon VA, 42. Matsushita T, Matsuoka T, Isobe N, Kawano Y, Minohara M, Shi N,
Rabinstein AA, Shuster E, Kantarci OH, Lucchinetti CF, Nishimura Y, Ochi H, Kira J. Association of the HLA-DPB1*0501
Weinshenker BG. Posterior reversible encephalopathy syndrome in allele with anti-aquaporin-4 antibody positivity in Japanese patients
neuromyelitis optica spectrum disorders. Neurology 2009;72:712-7. with idiopathic central nervous system demyelinating disorders.
25. Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical Tissue Antigens 2009;73:171-6.
features, immunopathogenesis and treatment. Clin Exp Immunol 43. Kira J. Neuromyelitis optica and opticospinal multiple sclerosis:
2014;176:149-64. mechanisms and pathogenesis. Pathophysiology 2011;18:69-79.
26. Graber DJ, Levy M, Kerr D, Wade WF. Neuromyelitis optica 44. Fukazawa T, Kikuchi S, Miyagishi R, Miyazaki Y, Yabe I, Hamada T,
pathogenesis and aquaporin 4. J Neuroinflammation 2008;5:22. Sasaki H. HLA-dPB1*0501 is not uniquely associated with
27. Asgari N. Epidemiological, clinical and immunological aspects of opticospinal multiple sclerosis in Japanese patients. Important role
neuromyelitis optica (NMO). Dan Med J 2013;60:B4730. of DPB1 * 0301. Mult Scler 2006;12:19-23.
28. Alexopoulos H, Kampylafka EI, Chatzi I, Travasarou M, 45. Ito H, Yamasaki K, Kawano Y, Horiuchi I, Yun C, Nishimura Y,

Neuroimmunol Neuroinflammation | Volume 1 | Issue 2 | September 2014 49